Medtronic Highlights Leadership in Inclusion, Diversity, and Equity in 2019 Integrated Performance Report
November 14 2019 - 02:00PM
Medtronic plc (NYSE:MDT) today released its fiscal year 2019 (FY19)
Integrated Performance Report: The Power of Purpose [view report
here].
The report focuses on Medtronic global corporate
citizenship efforts, which include the economic, social, and
environmental areas where the company can make the greatest impact.
It details FY19 progress against four pillars of Medtronic global
corporate citizenship and sustainability: Adding Value to Society,
Promoting Environmental Stewardship, Supporting a Global Workforce,
and Working Responsibly. Within the report, Medtronic addresses key
issues critical to the company and its stakeholders, such as access
to care, product stewardship, ethics in sales and marketing,
responsible supply management, and product quality.
“Our foremost priority is to contribute to human
welfare,” said Omar Ishrak, Medtronic chairman and chief executive
officer. “Today we are executing on the strongest product pipeline
in Medtronic’s history, bringing to market a long list of
technology innovations that will, in the words of our Mission,
alleviate pain, restore health, and extend life for millions of
people around the world.”
The report also highlights the company’s
commitment to recognizing the personal worth of all employees,
including providing equal pay for equal work. In FY19, Medtronic
achieved 99% overall for gender pay equity — and 100% in several
countries, including the United States. A further U.S. ethnic
diversity analysis found that for every $1.00 Caucasian employees
earned, ethnically diverse employees in equivalent roles earned
$0.99.
“While we are pleased with these results, I assure
you that our journey won’t stop until we ensure and sustain 100%
pay equity for all,” said Ishrak.
In FY19, Medtronic reported ethnically diverse
talent held 22% of leadership positions in the United States —
surpassing the company’s 2020 target of 20% or more. In addition,
38% of all global leadership positions were held by women, on track
to meet the company’s 2020 target of 40% or more, putting us closer
to our ultimate aspiration of 50%. Medtronic’s continued commitment
to inclusion and diversity is further described through the
company’s inaugural Global Inclusion, Diversity, and Equity Report
[view report here].
Other highlights from the 2019 Integrated
Performance Report include:
- 75 million+ lives improved through Medtronic
technologies and services
- $2.3 billion invested in research and
development
- 275+ ongoing clinical studies
- $142 million invested in training
for 80,000+ medical professionals
- $1 billion+ in philanthropic contributions to
date
- 38% reduction in greenhouse gas emissions
since 2013
- 35% of total energy needs sourced from
renewables
- $4.3 million in operational cost savings from
energy conservation projects
- $77.5 million spent on employee learning and
development
The report was prepared in accordance with the
Global Reporting Initiative Standard Core guidelines and the
Sustainability Accounting Standards Board disclosure standard for
the Medical Equipment & Supplies industry. For the first time,
Medtronic also shares its contribution to the UN Sustainable
Development Goals. The report, corresponding Standards Supplement,
and report executive summary are available for download
here.
For more information,
visit Medtronic.com/citizenship.
About MedtronicMedtronic plc
(www.medtronic.com), headquartered in Dublin, Ireland, is among the
world's largest medical technology, services and solutions
companies — alleviating pain, restoring health and extending life
for millions of people around the world. Medtronic employs more
than 90,000 people worldwide, serving physicians, hospitals and
patients in more than 150 countries. The company is focused on
collaborating with stakeholders around the world to take healthcare
Further, Together.
Any forward-looking statements are subject to
risks and uncertainties such as those described in Medtronic's
periodic reports on file with the Securities and Exchange
Commission. Actual results may differ materially from anticipated
results.
-end-
Erika WinkelsPublic Relations+1-763-526-8478
Ryan WeispfenningInvestor Relations+1-763-505-4626
Medtronic (NYSE:MDT)
Historical Stock Chart
From Feb 2024 to Mar 2024
Medtronic (NYSE:MDT)
Historical Stock Chart
From Mar 2023 to Mar 2024